Grace Therapeutics Inc (GRCE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access GRCE Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Grace Therapeutics Inc adapts its asset base and funding mix.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent13.76
Cash & Short-term Investments13.00
Other Receivables0.00
Nontrade Receivables, Current0.02
Prepaid Expense, Current AS0.56
Total Current Assets14.33
Equipment/Property/Plant Net0.01
Goodwill net8.14
Intangible Assets27.60
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset-
Total Assets50.07
Liabilities
Accounts Payable and Accrued Liabilities, Current LI1.25
Accrued Liabilities, Current0.42
Total Current Liabilities1.25
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent0.19
DeferredIncomeTaxLiabilitiesNet3.33
Operating Lease Liability Current0.00
Total Liabilities1.86
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock298.52
Retained Earnings / Accumulated Deficit-244.27
Accumulated Other Comprehensive Income-6.04
Other Equity-6.04
Common Stockholder's Equity48.21
Total Stockholder's Equity48.21
Liabilities & Stockholder's Equity50.07
4 historic quarters locked

Sign in to unlock the full Grace Therapeutics Inc balance sheet history.

About Grace Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001140361-26-032632

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.